Pharma-Bio Serv (PBSV) Shares Outstanding (Weighted Average) (2010 - 2026)

Pharma-Bio Serv (PBSV) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $22.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.23% year-over-year to $22.9 million; the trailing twelve-month figure through Jan 2026 stood at $22.9 million (changed 0.23% YoY), and the FY2025 full-year result was $22.9 million, changed 0.08% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $22.9 million, roughly flat from $22.9 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $23.0 million in Q4 2022 and bottomed at $22.9 million in Q1 2026.
• The 5-year median for Shares Outstanding (Weighted Average) is $23.0 million (2024), against an average of $23.0 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) decreased 0.34%; it then grew 0.08% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $23.0 million in 2022, then fell by 0.14% to $23.0 million in 2023, then slipped by 0.02% to $23.0 million in 2024, then slipped by 0.08% to $22.9 million in 2025, then fell by 0.18% to $22.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $22.9 million (Q1 2026), $22.9 million (Q4 2025), and $22.9 million (Q3 2025), per Business Quant data.

Peer Comparison